A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Participants

Clinical trial NCT04215991 · COMPLETED

Trial details

NCT number: NCT04215991
Sponsor: Shionogi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gram-negative Bacterial Infections Hospital Acquired Bacterial Pneumonia (HABP)Complicated Urinary Tract Infection (cUTI)Ventilator Associated Bacterial Pneumonia (VABP)

Start date: 2020-02-19
Primary completion: 2024-09-17
Enrollment: 91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.